Allan Butterfield
University of Kentucky
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Allan Butterfield.
Biochimica et Biophysica Acta | 1977
Allan Butterfield
Comparison of electron spin resonance spectra of spin labeled erythrocyte membranes from patients with the dystrophic conditions Duchenne and myotonic muscular dystrophy with those of normal controls suggests that alterations in membrane protein conformation and/or organization are present in these disease states. These protein alterations are not apparent in the non-dystrophic disease congenital myotonia. The results suggest a correlation between changes in the physical state of proteins in membranes with the presence of dystrophy. In addition, the present results from erythrocytes lend support for the concept of a generalized membrane defect in these diseases.
Amino Acids | 2007
Marta Piroddi; I. Depunzio; Vittorio Calabrese; Cesare Mancuso; C. M. Aisa; L. Binaglia; Alba Minelli; Allan Butterfield; Francesco Galli
Summary.End stage renal disease (ESRD) patients accumulate blood hallmarks of protein glycation and oxidation. It is now well established that these protein damage products may represent a heterogeneous class of uremic toxins with pro-inflammatory and pro-oxidant properties. These toxins could be directly involved in the pathogenesis of the inflammatory syndrome and vascular complications, which are mainly sustained by the uremic state and bioincompatibility of dialysis therapy. A key underlying event in the toxicity of these proteinaceous solutes has been identified in scavenger receptor-dependent recognition and elimination by inflammatory and endothelial cells, which once activated generate further and even more pronounced protein injuries by a self-feeding mechanism based on inflammation and oxidative stress-derived events. This review examines the literature and provides original information on the techniques for investigating proteinaceous pro-inflammatory toxins. We have also evaluated therapeutic – either pharmacological or dialytic – strategies proposed to alleviate the accumulation of these toxins and to constrain the inflammatory and oxidative burden of ESRD.
Journal of Neurochemistry | 2012
Fabio Di Domenico; Gabriella Casalena; Jia Jia; Rukhsana Sultana; Eugenio Barone; Jian Cai; William M. Pierce; Chiara Cini; Cesare Mancuso; Marzia Perluigi; Catherine M. Davis; Nabil J. Alkayed; Allan Butterfield
J. Neurochem. (2012) 121, 680–692.
Future Neurology | 2012
Rajesh Khanna; Sarah M. Wilson; Joel M. Brittain; Jill M. Weimer; Rukhsana Sultana; Allan Butterfield; Kenneth Hensley
Biochimica et Biophysica Acta | 1993
Kenneth Hensley; Jennifer Postlewaite; Pamela Dobbs; Allan Butterfield
Free Radical Biology and Medicine | 2017
Luksana Chaiswing; Chontida Yarana; Dustin Carroll; Michael C. Alstott; Allan Butterfield; Subbarao Bondada; Ines Batinic-Haber; Ivan Spasojevic; Daret K. St. Clair
Free Radical Biology and Medicine | 2016
Chontida Yarana; Dustin Carroll; Luksana Chaiswing; Yanming Zhao; Teresa Noel; Michael Alstotte; Jing Chen; Haining Zhu; Younsoo Bae; Emily Van Meter Dressler; Jeffrey A. Moscow; Allan Butterfield; Daret K. St. Clair
Free Radical Biology and Medicine | 2015
Chontida Yarana; Dustin Carroll; Luksana Chaiswing; Yanming Zhao; Teresa Noel; Michael C. Alstott; Mihail I. Mitov; Jing Chen; Haining Zhu; Allan Butterfield; Daret K. St. Clair
Journal of Neurochemistry | 2012
F. Di Domenico; Gabriella Casalena; Jia Jia; Rukhsana Sultana; Eugenio Barone; Jian Cai; William M. Pierce; Chiara Cini; Cesare Mancuso; Marzia Perluigi; Catherine M. Davis; Nabil J. Alkayed; Allan Butterfield
Archive | 2008
Jitbanjong Tangpong; Daret K. St. Clair; Allan Butterfield; Mary Vore; Steven Estus; William H. St. Clair